MENSTRUAL CRAMPS TREATMENT MARKET ANALYSIS

Menstrual Cramps Treatment Market, By Drug Class (Analgesics, Anticholinergics, Non-steroidal anti-inflammatory drugs, Haematinics, and Others (Progestins, Among others)), By Type (Primary Dysmenorrhea and Secondary Dysmenorrhea), By Route of Administration (Oral, Injectable, Topical, Intrauterine, and Others (Intrauterine, Among others)), By Dosage Form (Tablet, Capsules, Suspension, and Others (Transdermal Patch, Among others)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : May 2023
Code : CMI5760
Pages :205
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Global Menstrual Cramps Treatment Market: Restraint

Availability of alternative treatment:

Availability of alternative treatment for the management of menstrual cramps hampering the market of menstrual cramps treatment. For Instance, on 3 Mar 2023, iPulse Medical Ltd. Offering medical device for the treatment of menstrual cramps. Livias Portable device, a drug free solution for menstrual pain is expected to hamper the market growth. Using proprietary SmartWave technology based on the gate control theory, Livia transmits special micro-pulses to keep the nerves “busy” and block the signals that cause period pain. Retrain can be overcome by increasing medical reimbursement on drugs which are indicated for the treatment of menstrual cramps.

Growth Drivers: